Omnicell (OMCL) Tops Q1 EPS by 20c, Revenues Beat; Offers 2Q & FY19 EPS Guidance Above Consensus, Affirms 2Q & FY19 Revenue Outlooks

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Omnicell (OMCL) Tops Q1 EPS by 20c, Revenues Beat; Offers 2Q & FY19 EPS Guidance Above Consensus, Affirms 2Q & FY19 Revenue Outlooks

Omnicell Reports Results for First Quarter 2019

April 25, 2019 4:01 PM EDT

MOUNTAIN VIEW, Calif., April 25, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its first quarter ended March 31, 2019.

GAAP Results

GAAP revenues for the first quarter of 2019 were $202.5 million, up $19.9 million, or 10.9% from the first quarter of 2018.

First... More